domperidone has been researched along with clonidine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Faassen, F; Spanings, H; Vogel, G; Vromans, H | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Brambilla, F; Catalano, M; Facchinetti, F; Ferrari, E; Genazzani, AR; Petraglia, F | 1 |
| Hedler, L; Starke, K; Szabo, B | 1 |
| Ensinger, H; Hedler, L; Majewski, H; Starke, K | 1 |
| Duarte, ID; Ferreira-Alves, DL; Nakamura-Craig, M; Veloso, DP | 1 |
| Anpalahan, M; Chisholm, P | 1 |
1 review(s) available for domperidone and clonidine
| Article | Year |
|---|---|
Orthostatic hypotension: pathophysiology, assessment, treatment and the paradox of supine hypertension.
Topics: Antihypertensive Agents; Antiparkinson Agents; Clonidine; Disease Management; Domperidone; Dopamine Antagonists; Droxidopa; Humans; Hypertension; Hypotension, Orthostatic; Immunosuppressive Agents; Prospective Studies; Supine Position | 2017 |
14 other study(ies) available for domperidone and clonidine
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cells; Cell Membrane Permeability; Heterocyclic Compounds; Humans; Protein Transport | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Peripheral opioid secretory pattern in anorexia nervosa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Anorexia Nervosa; beta-Endorphin; beta-Lipotropin; Body Weight; Circadian Rhythm; Clonidine; Corticotropin-Releasing Hormone; Domperidone; Endorphins; Female; Humans; Receptors, Opioid; Secretory Rate | 1991 |
Dopamine1 receptor agonist and alpha-2 adrenoceptor antagonist effects of fenoldopam in rabbits.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Clonidine; Decerebrate State; Desipramine; Domperidone; Drug Interactions; Electric Stimulation; Electrophysiology; Female; Fenoldopam; Male; Norepinephrine; Pulmonary Artery; Rabbits; Receptors, Dopamine; Sympathetic Nervous System | 1986 |
Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
Topics: Anesthesia; Animals; Benzazepines; Blood Pressure; Bromocriptine; Clonidine; Decerebrate State; Desipramine; Domperidone; Dopamine; Female; Male; Neurons; Nitroprusside; Norepinephrine; Propranolol; Rabbits; Receptors, Dopamine; Receptors, Neurotransmitter | 1985 |
Evidence of the involvement of biogenic amines in the antinociceptive effect of a vouacapan extracted from Pterodon polygalaeflorus Benth.
Topics: Analgesics, Non-Narcotic; Animals; Brazil; Clonidine; Diterpenes; Domperidone; Dopamine; Guanethidine; Male; Mice; Plant Extracts; Plants, Medicinal; Yohimbine | 1996 |